A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Clinical trial NCT03643159 · TERMINATED
Trial details
- NCT number
- NCT03643159
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-28
- Primary completion
- 2018-10-17
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.